Nicole M. Stack

Albany College of Pharmacy and Health Sciences

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Kelly Rudd

Oklahoma State University Center for Health Sciences

Raja Rizwan Hussain

Mathrusri Ramabai Ambedkar Dental College & Hospital

B. Lee

St. Vincent's University Hospital

M. X. FitzGerald

Sanofi (United States)

Luke Clancy

TobaccoFree Research Institute

V. Hegarty

University Hospital Galway

Reza Mofidi

James Cook University Hospital

Shri Pathmakanthan

Queen Elizabeth Hospital Birmingham

T. M. Healy

St. Mary's Health System

Maria Tahir

Combined Military Hospital

Cooperative Institutions

Beaumont Hospital

St. Vincent's University Hospital

University College Dublin

Royal College of Surgeons in Ireland

St. James's Hospital

St. Vincent's Hospital

Trinity College Dublin

St Vincent's Hospital

University Hospital Galway

Tallaght University Hospital

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Collaborative development of a longitudinal patient case in a team-taught introductory pharmacotherapy module.

Nicole M. Stack Mario M. Zeolla Sarah L Scarpace Michael Brodeur Darren W. Grabe

Pharmacotherapy

Source

Cite

Citations (0)

Cultural competency for new practitioners

American Journal of Health-System Pharmacy (2006)

Kelly Rudd Nicole M. Stack

Journal Article Cultural competency for new practitioners Get access Kelly M. Rudd, Pharm.D., BCPS, Kelly M. Rudd, Pharm.D., BCPS Clinical Specialist Department of Pharmaceutical Care Services Bassett Healthcare 1 Atwell Road Cooperstown, NY 13326 kelly.rudd@bassett.org Search for other works by this author on: Oxford Academic Google Scholar Nicole M. Stack, Pharm.D. Nicole M. Stack, Pharm.D. Assistant Professor of Pharmacy Practice Albany College of Pharmacy Albany, NY Search for other works by this author on: Oxford Academic Google Scholar American Journal of Health-System Pharmacy, Volume 63, Issue 10, 15 May 2006, Pages 912–913, https://doi.org/10.2146/ajhp050120 Published: 15 May 2006

10.2146/ajhp050120

Cite

Citations (7)

Smoking Cessation: An Overview of Treatment Options with a Focus on Varenicline

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2007)

Nicole M. Stack

Tobacco use claims more than 440,000 lives each year, making it one of the leading causes of mortality in the United States. Although nearly half of all people who smoke die prematurely from tobacco-related illnesses, those who quit may be able to reverse many of the adverse effects of tobacco. Approximately 47.5 million adults use tobacco; nearly 70% of them want to quit, and 42.5% attempt to quit each year. The most effective smoking cessation programs involve a combination of pharmacotherapy and behavioral and/or cognitive counseling to improve abstinence rates. Approved treatments include nicotine replacement therapies and bupropion, a non nicotine option. Varenicline, the most recent agent approved for tobacco cessation, is the first drug in a new class that binds to the nicotinic receptors to release dopamine and alleviate withdrawal symptoms. It has demonstrated superior efficacy in clinical trials when compared with placebo and bupropion, with minimal adverse effects. It provides smokers and clinicians with an alternative therapy to assist in quitting tobacco.

Varenicline

Bupropion

Nicotine replacement therapy

Pharmacotherapy

Nicotine withdrawal

10.1592/phco.27.11.1550

Cite

Citations (30)

Implementation of inpatient and outpatient tobacco-cessation programs

American Journal of Health-System Pharmacy (2007)

Nicole M. Stack Alan J. Zillich

Two programs in which pharmacists have an active role in the provision of tobacco-cessation education are described.An algorithm for tobacco- cessation education was created for use in an inpatient tobacco-cessation program. Patient education handouts were created, and the content of each handout varied by the patient's level of readiness to make a quit attempt. Doctor of pharmacy students who were assigned to the general internal medicine clerkship rotation at the hospital provided tobacco-cessation education to patients. During monthly rotations, these students assess the smoking status of each patient, gauge the patient's readiness to quit, and provide brief tobacco-cessation education to those who smoke. Patients who are willing to quit smoking are asked if they can be contacted by a representative of the health system's tobacco-cessation program. This program includes a series of three group classes focusing on behavior modification and pharmacotherapy provided at a discounted price. An outpatient tobacco-cessation clinic was initiated to provide all patients of the network an opportunity to participate and have access to tobacco-cessation services. The clinic consists of group and individual classes using the principles and interventions highlighted in national clinical practice guidelines. All referred patients must attend an initial one-on-one visit with the clinical pharmacist before enrollment into the group class. During this visit, general medical information is collected, and the patient's stage of change and willingness to set a quit date are determined. A medication review for drug-smoking interactions is conducted, individual goals are discussed, and a care plan is created.Tobacco-cessation services were implemented by pharmacists working in inpatient and outpatient settings.

10.2146/ajhp060410

Cite

Citations (11)

Smoking cessation therapy considerations for patients with chronic kidney disease.

PubMed (2008)

Harold J. Manley Nicole M. Stack

Cigarette smoking is a readily modifiable cardiovascular and chronic kidney disease (CKD) risk factor. Smoking cessation aids include nicotine replacement therapy (NRT), bupropion, and varenicline. Several reports suggest that patients with CKD who use tobacco products be encouraged to stop; however, very little is offered to the healthcare provider as to how to successfully prescribe and monitor smoking cessation therapy for this patient population. This article reviews NRT, bupropion, and varenicline pharmacokinetics and dosing literature for patients with CKD. Evidence for the benefit of smoking cessation in patients with CKD is also reviewed.

Varenicline

Bupropion

Nicotine replacement therapy

Pharmacotherapy

Source

Cite

Citations (6)

AACP REPORTS Roster of Voting Delegates, 2008 AACP Annual Meeting, Chicago, Illinois

Mehdi Boroujerdi Nicole M. Stack Sarah T. Melton John E. Murphy Brian L. Erstad

Source

Cite

Citations (0)

Irish thoracic society

Irish Journal of Medical Science (1971 -) (1993)

Cliodhna Quigley Reza Mofidi G. Liu C. M. O’Connor M. X. FitzGerald

10.1007/bf02996325

Cite

Citations (0)

Advanced pharmacy practice for new practitioners

American Journal of Health-System Pharmacy (2006)

Nicole M. Stack Kelly Rudd

Advanced practices in health care increase efforts to reduce costs, improve health outcomes, and increase access to medications and the amount of health-related information available from the Internet.1 These health care changes shape practice for pharmacists who must change to meet the demands of advanced practice. Two of the most prominent examples of advanced pharmacy practice are collaborative drug therapy management and immunization by pharmacists. Pharmacists, when involved in advanced practice settings, have contributed to significant reductions in the number of adverse drug reactions and improvement in other measurable outcomes.2,–4 Studies have also highlighted the role and beneficial impacts of pharmacist-run immunization clinics to improve influenza and pneumococcal vaccination rates.5,6 The Pharmacists as Immunizers program allows pharmacists to bill for cognitive services under the Medicare Prescription Drug, Improvement, and Modernization Act for 2006 and can be associated with potential cost savings.7,–9 For new practitioners to successfully develop and engage in advanced practice and collaborative agreements, it is important to examine some of the key factors: support from other health care providers, the changing role of the pharmacist in an expanding scope of practice, the education of new practitioners, and the key components of pharmacy legislation.

Scope of Practice

10.2146/ajhp050472

Cite

Citations (2)

Impact of Clinical Elective Coursework on Student Pharmacists' Attitudes towards Patient Care Services

Nicole M. Stack Nimish Patel Sara E. Dugan

Coursework

Patient Care

Source

Cite

Citations (0)